Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Alzheimer Disease

Interventions

DRUG

[18F] MNI-558

Subjects will be injected with 5mCi, not to exceed \>10% of 5mCI, of \[18F\]MNI-558, followed by PET imaging.

Trial Locations (1)

Institute for Neurodegenerative Disorders, New Haven